Terms: = Cervical cancer AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Prognosis
24 results:
1. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
2. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of cervical Squamous Cell Carcinoma.
Wang L; Qu H; Ma X; Liu X
Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
[TBL] [Abstract] [Full Text] [Related]
4. Recurrent or primary metastatic cervical cancer: current and future treatments.
Gennigens C; Jerusalem G; Lapaille L; De Cuypere M; Streel S; Kridelka F; Ray-Coquard I
ESMO Open; 2022 Oct; 7(5):100579. PubMed ID: 36108558
[TBL] [Abstract] [Full Text] [Related]
5. Total Pharyngo-Laryngo-cervical-Esophagectomy with Jejunal Free Flap Reconstruction in a Developing Country: A Case Report from Vietnam.
Van BP; Tien HN; Van NH; Viet DD; Thanh HNT
Am J Case Rep; 2022 Mar; 23():e934974. PubMed ID: 35342189
[TBL] [Abstract] [Full Text] [Related]
6. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
7. TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.
Kuno I; Takayanagi D; Asami Y; Murakami N; Matsuda M; Shimada Y; Hirose S; Kato MK; Komatsu M; Hamamoto R; Okuma K; Kohno T; Itami J; Yoshida H; Shiraishi K; Kato T
Sci Rep; 2021 Sep; 11(1):19261. PubMed ID: 34584128
[TBL] [Abstract] [Full Text] [Related]
8. Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
Tian X; Ge D; Zhang F; Zhang B; Bai W; Xu X; Li Z; Cao Y; Li P; Zou K; Zou L
Int J Cancer; 2021 Feb; 148(4):921-931. PubMed ID: 33113150
[TBL] [Abstract] [Full Text] [Related]
9. [Update for Diagnosis and Management of HPV-Driven Oropharyngeal cancer].
Broglie Däppen MA
Praxis (Bern 1994); 2020 Jul; 109(9):697-703. PubMed ID: 32635845
[TBL] [Abstract] [Full Text] [Related]
10. Mucinous breast carcinoma metastatic to thyroid gland: Report of a case diagnosed by fine-needle aspiration cytology.
Wang M; Liu X; Wei B; Liu N; Li Q; Su X
Diagn Cytopathol; 2020 May; 48(5):475-478. PubMed ID: 32065477
[TBL] [Abstract] [Full Text] [Related]
11. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract] [Full Text] [Related]
12. Lymphoma of the Cervix: Case Report and Review of the Literature.
Hilal Z; Hartmann F; Dogan A; Cetin C; Krentel H; Schiermeier S; Schultheis B; Tempfer CB
Anticancer Res; 2016 Sep; 36(9):4931-40. PubMed ID: 27630351
[TBL] [Abstract] [Full Text] [Related]
13. Loss of fbxw7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
Xu Y; Yu J; Liu T; Meng F; Kong D; Lou G
Biomarkers; 2016; 21(4):379-85. PubMed ID: 26954701
[TBL] [Abstract] [Full Text] [Related]
14. Axillary lymph nodes metastasis in a patient with recurrent papillary thyroid cancer: a case report.
Hafez MT; Refky B; Elwahab KA; Arafa M; Abdou I; Elnahas W
J Med Case Rep; 2015 Aug; 9():181. PubMed ID: 26307101
[TBL] [Abstract] [Full Text] [Related]
15. Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.
Spaans VM; Trietsch MD; Crobach S; Stelloo E; Kremer D; Osse EM; Haar NT; van Eijk R; Muller S; van Wezel T; Trimbos JB; Bosse T; Smit VT; Fleuren GJ
PLoS One; 2014; 9(3):e93451. PubMed ID: 24671188
[TBL] [Abstract] [Full Text] [Related]
16. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting.
Amant F; Halaska MJ; Fumagalli M; Dahl Steffensen K; Lok C; Van Calsteren K; Han SN; Mir O; Fruscio R; Uzan C; Maxwell C; Dekrem J; Strauven G; Mhallem Gziri M; Kesic V; Berveiller P; van den Heuvel F; Ottevanger PB; Vergote I; Lishner M; Morice P; Nulman I;
Int J Gynecol Cancer; 2014 Mar; 24(3):394-403. PubMed ID: 24445819
[TBL] [Abstract] [Full Text] [Related]
17. Pulmonary lymphangitic carcinomatosis from squamous cell carcinoma of the cervix.
Kanthan R; Senger JL; Diudea D
World J Surg Oncol; 2010 Dec; 8():107. PubMed ID: 21129213
[TBL] [Abstract] [Full Text] [Related]
18. Multispectral real-time fluorescence imaging for intraoperative detection of the sentinel lymph node in gynecologic oncology.
Crane LM; Themelis G; Buddingh KT; Harlaar NJ; Pleijhuis RG; Sarantopoulos A; van der Zee AG; Ntziachristos V; van Dam GM
J Vis Exp; 2010 Oct; (44):. PubMed ID: 21048667
[TBL] [Abstract] [Full Text] [Related]
19. Metastasis of carcinoma of the uterine cervix to the nasal dorsum.
Ozdemir H; Tunçbilek G
J Craniofac Surg; 2009 May; 20(3):971-3. PubMed ID: 19461347
[TBL] [Abstract] [Full Text] [Related]
20. cancer in 15- to 29-year-olds by primary site.
Bleyer A; Viny A; Barr R
Oncologist; 2006 Jun; 11(6):590-601. PubMed ID: 16794238
[TBL] [Abstract] [Full Text] [Related]
[Next]
